Spots Global Cancer Trial Database for intestinal obstruction
Every month we try and update this database with for intestinal obstruction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer | NCT01196494 | Colon Neoplasm Colorectal Surg... Intestinal Obst... | intraoperative ... | 18 Years - | Corporacion Parc Tauli | |
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | NCT05229822 | Intestinal Obst... Colorectal Canc... Post-Op Complic... Systemic Inflam... Colon Tumor | LBP sCD14-ST 16s rRNA | 18 Years - | Karaganda Medical University | |
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer | NCT04039360 | Complication of... | self-expanding ... | 18 Years - 80 Years | Beijing Chao Yang Hospital | |
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients | NCT01669044 | Abdominal Tumor Intestinal Obst... Cirrhosis Intestinal Fist... Aneurism | dexmedetomidine propofol | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | NCT05229822 | Intestinal Obst... Colorectal Canc... Post-Op Complic... Systemic Inflam... Colon Tumor | LBP sCD14-ST 16s rRNA | 18 Years - | Karaganda Medical University | |
Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer | NCT01196494 | Colon Neoplasm Colorectal Surg... Intestinal Obst... | intraoperative ... | 18 Years - | Corporacion Parc Tauli | |
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients | NCT01669044 | Abdominal Tumor Intestinal Obst... Cirrhosis Intestinal Fist... Aneurism | dexmedetomidine propofol | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University |